Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp; Christine Cornforth; Richard Jackson; Jane Harrold; Mark A Turner; Louise Kenny; Philip N Baker; Edward D Johnstone; Asma Khalil; Peter von Dadelszen; Aris T Papageorghiou; Zarko Alfirevic

doi:10.1016/S2352-4642(19)30020-3

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner, Louise Kenny, Philip N Baker, Edward D Johnstone, Asma Khalil, Peter von Dadelszen, Aris T Papageorghiou, Zarko Alfirevic

Division of Developmental Biology & Medicine (L5)

Research output: Contribution to journal › Letter › peer-review

10 Downloads (Pure)

Original language	English
Pages (from-to)	e2-e3
Journal	The Lancet Child & Adolescent Health
Volume	3
Issue number	3
Early online date	28 Jan 2019
DOIs	https://doi.org/10.1016/S2352-4642(19)30020-3
Publication status	Published - 1 Mar 2019

Access to Document

10.1016/S2352-4642(19)30020-3

Commentary for Lancet FINALAccepted author manuscript, 31.7 KB

Cite this

Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., Baker, P. N., Johnstone, E. D., Khalil, A., von Dadelszen, P., Papageorghiou, A. T., & Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. The Lancet Child & Adolescent Health, 3(3), e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

@article{2fadfd1cc7a84578ba4d05f7cac3907f,

title = "Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction",

author = "Andrew Sharp and Christine Cornforth and Richard Jackson and Jane Harrold and Turner, {Mark A} and Louise Kenny and Baker, {Philip N} and Johnstone, {Edward D} and Asma Khalil and {von Dadelszen}, Peter and Papageorghiou, {Aris T} and Zarko Alfirevic",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/S2352-4642(19)30020-3",

language = "English",

volume = "3",

pages = "e2--e3",

journal = "The Lancet Child & Adolescent Health",

issn = "2352-4642",

publisher = "Elsevier BV",

number = "3",

}

Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, MA, Kenny, L, Baker, PN, Johnstone, ED, Khalil, A, von Dadelszen, P, Papageorghiou, AT & Alfirevic, Z 2019, 'Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction', The Lancet Child & Adolescent Health, vol. 3, no. 3, pp. e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

TY - JOUR

T1 - Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

AU - Sharp, Andrew

AU - Cornforth, Christine

AU - Jackson, Richard

AU - Harrold, Jane

AU - Turner, Mark A

AU - Kenny, Louise

AU - Baker, Philip N

AU - Johnstone, Edward D

AU - Khalil, Asma

AU - von Dadelszen, Peter

AU - Papageorghiou, Aris T

AU - Alfirevic, Zarko

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85061374987&partnerID=8YFLogxK

U2 - 10.1016/S2352-4642(19)30020-3

DO - 10.1016/S2352-4642(19)30020-3

M3 - Letter

C2 - 30704877

SN - 2352-4642

VL - 3

SP - e2-e3

JO - The Lancet Child & Adolescent Health

JF - The Lancet Child & Adolescent Health

IS - 3

ER -

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Access to Document

Other files and links

Cite this